Opinion for the court filed by Circuit Judge MAYER. Dissenting opinion filed by Circuit Judge GAJARSA.
MAYER, Circuit Judge.
Tyco Healthcare Group, LP (“Tyco”) appeals a judgment of the United States District Court for the District of Delaware entered after a jury determined that Tyco’s Monoject Magellan™ safety needles and blood collection devices literally infringed claims 1-4, 6, 12, 13, 15, 24 and 27 of U.S. Patent No. 5,348,544 (the “'544 patent”). Because we conclude that the district court incorrectly construed the “spring means” limitation of the asserted claims and erred in denying Tyco’s motion for judgment as a matter of law (“JMOL”), we reverse.
Background
Becton, Dickinson and Company (“Becton”) is the assignee of the '544 patent, which is directed toward a safety needle designed to prevent accidental needle stick injuries. The safety shield, or needle guard, of the patented invention is initially positioned at the base of the needle, next to the needle hub. This is called the “first position” and is shown in figure 2 of the '544 patent.
[[Image here]]
The guard is mounted on or close to the needle cannula and is attached to the needle hub by a hinged arm. When the guard is in the first position, the hinged arm is folded. When the needle has been removed from a patient, the health care worker pushes the hinged arm forward, causing the hinged arm to unfold and the guard to move along the needle cannula toward the tip of the needle. When the guard covers the needle tip, it is said to be in its “second position” as shown in figure 4.
[1251]*1251[[Image here]]
To facilitate the movement of the guard toward the needle tip, the '544 patent discloses a “spring means” for “urging [the] guard along [the] needle cannula.” The specification describes two embodiments in which a spring moves the guard down the needle cannula. The specification does not attribute any movement of the guard to the hinged arm of the safety needle.
On December 23, 2002, Becton filed suit against Tyco, alleging infringement of the '544 patent by Tyco’s Monoject Magellan™ safety needles and blood collection devices. Becton subsequently answered Tyco’s first set of interrogatories, including interrogatory 3, which called for an infringement claim chart “fully explaining] how each claim element is met either literally or under the doctrine of equivalents in each Tyco product accused of infringement.” In response, Becton identified the living hinges in Tyco’s accused devices as satisfying the “spring means” limitation of asserted claims 1 and 24 and stated that “[o]nce released, the spring means urges the guard along the needle cannula toward” the tip of the needle. Later, in updated infringement charts served on Tyco just prior to the close of fact discovery, Becton reiterated its assertion that “[o]nce released, the spring means urges the guard along the needle cannula” toward the needle tip.
After the close of fact discovery, Becton issued its only expert report on infringement. Becton’s expert, Charles A. Garris, Jr., explained his theory as to how the hinges in the hinged arm of Tyco’s accused devices functioned as springs:
The hinged arm [in Tyco’s accused products] is ... folded and assembled with the other components of the safety assembly. I expect to explain that folding of the hinged arm imparts stress to the hinge that results in a certain amount of stored energy. In the accused Tyco Monoject Magellan™ devices, the force of this stored energy is initially restrained by a latching mechanism. Once unlatched, the stored energy is released, causing the safety guard to be urged (i.e., moved) along the needle cannula toward the tip of the needle.
On May 3, 2004, Tyco moved for summary judgment of non-infringement, arguing that the spring means limitation of the asserted claims required a spring separate from the hinged arm structure. The district court denied this motion, however, rejecting Tyco’s argument that a proper construction of the spring means limitation requires “a separate spring [which] must move the guard along the cannula toward the second position.” Becton, Dickinson & Co. v. Tyco Healthcare Group, LP, No. 02-1694 GMS, 2004 WL 2075413 at *4, 2004 U.S. Dist. LEXIS 18637 at *12 (D.Del. Sept. 16, 2004) (“Summary Judgment Decision ”).
On October 26, 2004, a jury returned a verdict finding literal infringement by both [1252]*1252of Tyco’s accused products.1 The jury found that the infringement was willful as to the Magellan safety needle, but not as to the Magellan blood collector; it also found that the patent was not invalid for lack of an adequate written description. Tyco subsequently moved for a new trial, arguing that Becton had improperly changed its theory of infringement during trial. The district court agreed, noting that the only infringement theory disclosed by Becton prior to trial was that “once unlatched” the hinges in the hinged arm caused the safety guard to move down the needle cannula:
From the outset, [this] case was postured on the assertion that Tyco’s Monoject Magellan devices infringed the “spring means” limitation of the ['544] patent because, after the devices are unlatched, the hinged arms move the guard toward the cannula of the needle. Dr. Garris’ expert statement, [Becton’s] summary judgment motion, and [Becton’s] pretrial memorandum in support of its claim of infringement and for damages, all make clear that the “after unlatching” theory was the only basis for Tyco’s alleged infringement.
Becton, Dickinson & Co. v. Tyco Healthcare Group, LP, No. 02-1694 GMS, 2006 WL 890995 at *10, 2006 U.S. Dist. LEXIS 14999 at *34-35 (D.Del. Mar. 31, 2006) (“New Trial Decision ”).
During trial, however, Becton reversed course, arguing that the living hinges in the hinged arm moved the guard before the hinged arm was unlatched. Id. at *12, 2006 U.S. Dist. LEXIS 14999 at *38-40. Because Becton had “advanced a new theory of infringement at trial” and its actions were “inconsistent with substantial justice ... and resulted in actual prejudice,” the district court granted Tyco’s motion for a new trial. Id. at *12, 2006 U.S. Dist. LEXIS 14999 at *40.
In January 2007, prior to the start of the second trial, Tyco filed a petition in the United States Patent and Trademark Office (“PTO”) requesting reexamination of the '544 patent based on Netherlands Patent Publication No. 9000909. The examiner in charge of the reexamination issued an office action in which she found that the “spring means” limitation in claims 1 and 24 of the '544 patent was a “means-plus-function” limitation and required that the spring means be a separate structural element from the hinged arm. See 35 U.S.C. § 112, ¶ 6. Tyco then filed a motion asking the district court to adopt the PTO’s construction of the disputed claims, but the court denied this motion on November 21, 2007.2
At the second trial, the district court instructed the jury that the spring means limitation required that “once the hinged arm is unlatched for the first time, the ‘spring means’ must move the guard along the needle toward the needle tip.” The trial court also instructed the jury that “[t]he spring is not required to move the guard all the way to the tip of the needle but must, by itself, move the guard for some distance.”
On November 30, 2007, a jury returned a verdict of infringement as to both of Tyco’s accused products. Tyco thereafter filed motions seeking JMOL and a new trial. The district court denied these motions, however, explaining that although it was a “close issue,” Becton had “adduced enough circumstantial evidence from which the jury could reasonably conclude that the living hinges of Tyco’s products are [1253]*1253springs that, by themselves, move the guard toward the needle tip once unlatched.” See Becton, Dickinson & Co. v. Tyco Healthcare Group, LP, No. 02-1694 GMS, 2008 WL 4610220 at *4, 2008 U.S. Dist. LEXIS 82915 at *10 (D.Del. Oct. 14, 2008) (footnote omitted) (“JMOL Decision ”).
Tyco then appealed to this court, challenging the district court’s interpretation of the asserted claims and the denial of its motions for JMOL and a new trial. Becton filed a conditional cross-appeal, arguing that if the district court’s judgment is reversed, it should be granted a new trial on the issue of whether Tyco infringed the '544 patent by manufacturing — rather than selling — the Magellan needles and blood collectors. We have jurisdiction pursuant to 28 U.S.C. § 1295(a)(1).
Discussion
Precedent requires that this court conduct a de novo review of claim construction. See Cybor Corp. v. FAS Techs., Inc., 138 F.3d 1448, 1456 (Fed.Cir.1998) (en banc). We review the denial of a JMOL motion “under the law of the regional circuit where the appeal from the district court would normally lie.” Muniauction, Inc. v. Thomson Corp., 532 F.3d 1318, 1323 (Fed.Cir.2008). In the Third Circuit, when determining whether to grant a JMOL motion “[t]he question is not whether there is literally no evidence supporting the party against whom the motion is directed but whether there is evidence upon which the jury could properly find a verdict for that party.” Lightning Lube, Inc. v. Witco Corp., 4 F.3d 1153, 1166 (3d Cir.1993) (citations and internal quotation marks omitted). “Although judgment as a matter of law should be granted sparingly,” it is mandated “where the record is critically deficient of the minimum quantum of evidence” necessary to support a jury verdict. Eshelman v. Agere Sys., Inc., 554 F.3d 426, 433 (3d Cir.2009) (internal quotation marks omitted).
I.
To establish literal infringement, “every limitation set forth in a claim must be found in an accused product, exactly.” Southwall Techs., Inc. v. Cardinal IG Co., 54 F.3d 1570, 1575 (Fed.Cir.1995). Thus, “[i]f any claim limitation is absent from the accused device, there is no literal infringement as a matter of law.” Amgen Inc. v. F. Hoffman-LA Roche, Ltd., 580 F.3d 1340, 1374 (Fed.Cir.2009). Tyco argues that its Monoject Magellan™ safety needle and blood collection devices do not literally infringe the '544 patent because they lack the added spring member required by the asserted claims. We agree. The unambiguous language of the asserted claims, as well as the disclosure in the specification, requires an added spring element that moves the safety guard toward the tip of the needle.3
Claim 1, which has been treated as representative, calls for a “spring means connected to said hinged arm for urging said guard along said needle cannula toward” the tip of the needle. Following a Markman hearing, the district court correctly construed this limitation to require that: “The hinged arm is connected to a spring that moves the guard along the cannula toward” the tip of the needle. By its plain terms, this construction contem[1254]*1254plates that the spring means and the hinged arm are separate structures which are “connected to” each other. The district court erred, however, when it later held that its claim construction did not require a spring means that was a distinct structural element from the hinged arm. See Summary Judgment Decision, 2004 WL 2075413 at *4, 2004 U.S. Dist. LEXIS 18637 at *12 (rejecting Tyco’s argument that a proper construction of the spring means limitation requires “a separate spring [which] must move the guard along the cannula toward the second position”).
Claim construction “begins and ends in all cases with the actual words of the claim.” Renishaw PLC v. Marposs Society per Azioni, 158 F.3d 1243, 1248 (Fed.Cir.1998). The unequivocal language of the asserted claims of the '544 patent requires a spring means that is separate from the hinged arm. Claim 1 recites:
1. A shieldable needle assembly comprising:
a needle cannula having a proximal end and a distal tip;
a guard having a proximal end, an opposed distal end and a side wall extending therebetween, said guard being slid-ably movable along said needle cannula from a first position substantially adjacent said proximal end of said needle cannula to a second position where said distal tip of said needle cannula is intermediate said opposed proximal and distal ends of said guard; a hinged arm having proximal and distal segments articulated to one another for movement between a first position where said segments are substantially collapsed onto one another and a second position where said segments are extended from one another, said proximal segment of said hinged arm being articulated to a portion of said needle assembly adjacent said proximal end of said needle cannula, said distal segment of said hinged arm being articulated to said guard, said proximal and distal segments of said hinged arm having respective lengths for permitting said guard to move from said first position to said second position on said needle cannula, and for preventing said guard from moving distally beyond said second position; and
spring means connected to said hinged arm for urging said guard along said needle cannula toward said second position.
'544 patent col.7 ll.7-35 (emphases added).
Claim 1 lists four separate elements: 1) a needle, 2) a guard that rides on the needle, 3) a hinged arm attached to the guard, and 4) a spring means “connected to” the hinged arm. Where a claim lists elements separately, “the clear implication of the claim language” is that those elements are “distinct eomponent[s]” of the patented invention. Gaus v. Conair Corp., 363 F.3d 1284, 1288 (Fed.Cir.2004); Engel Indus., Inc. v. Lockformer Co., 96 F.3d 1398, 1404-05 (Fed.Cir.1996) (concluding that where a claim provides for two separate elements, a “second portion” and a “return portion,” these two elements “logically cannot be one and the same”). There is nothing in the asserted claims to suggest that the hinged arm and the spring means can be the same structure. See CAE Screenplates, Inc. v. Heinrich Fiedler GmbH & Co., 224 F.3d 1308, 1317 (Fed.Cir.2000) (“In the absence of any evidence to the contrary, we must presume that the use of ... different terms in the claims connotes different meanings.”).
The specification, moreover, confirms that the spring means is a separate element from the hinged arm, as the only elements disclosed in the specification as “spring means” for urging the guard forward are separate structures from the hinged arm and its hinges. There is no suggestion that the hinged arm or its hing[1255]*1255es can function as springs, because nothing in the specification describes the hinges as moving the guard or even helping to move the guard. Nothing in the specification indicates that the hinges in the hinged arm might contain sufficient stored energy to enable them to move the safety guard toward the tip of the needle. To the contrary, the specification cautions that it is undesirable to allow stored energy to act for any extended period on the plastic parts of the needle assembly. See '544 patent col.5 11.12-13 (explaining that “stored energy acting on plastic can affect the reliability and performance of the part”). In short, the specification comports with the plain language of the claims, fully supporting the conclusion that the spring means is a separate structural component of the patented invention. See Astrazeneca AB v. Mut. Pharm. Co., 384 F.3d 1333, 1336 (Fed.Cir.2004) (“A long line of cases indicates that evidence intrinsic to the patent — particularly the patent’s specification, including the inventors’ statutorily-required written description of the invention — is the primary source for determining claim meaning.”); Vitronics Corp. v. Conceptronic, Inc., 90 F.3d 1576, 1582 (Fed.Cir.1996) (The specification is “is the single best guide to the meaning of a disputed [claim] term.”).
Indeed, Becton’s assertion that the spring means and the hinged arm can be the same structure renders the asserted claims nonsensical. Independent claim 1 of the '544 patent describes the spring means as being “connected to” the hinged arm and independent claim 24 describes it as “extending between” the hinged arm and a mounting means.4 If the hinged arm and the spring means are one and the same, then the hinged arm must be “connected to” itself and must “extend between” itself and a mounting means, a physical impossibility. A claim construction that renders asserted claims facially nonsensical “cannot be correct.” Schoenhaus v. Genesco, Inc., 440 F.3d 1354, 1357 (Fed.Cir.2006); see Bd. of Regents v. BENQ Am. Corp., 533 F.3d 1362, 1370 (Fed.Cir.2008) (refusing to adopt a claim construction that “would effect [a] nonsensical result”).
Furthermore, if the hinged arm and spring means are not separate structures, then the asserted claims are clearly invalid as obvious over the prior art. See Whittaker Corp. v. UNR Indus., Inc., 911 F.2d 709, 712 (Fed.Cir.1990) (“[C]laims are generally construed so as to sustain their validity, if possible.”). The first three elements of Becton’s claimed invention — the needle, the protective guard, and the hinged arm — were disclosed in several prior art patents. See U.S. Patent Nos. 4,911,706; 4,898,589; 4,790,828. The Hagen patent, U.S. Patent No. 4,735,618, specifically discloses a safety needle, a guard and a hinged arm, which includes hinges comprised of thinned pieces of plastic. What distinguished the claimed invention from the prior art was the addition of a spring means separate from the hinged arm. See '544 patent col.l 11.33-34 (discussing “prior art needle shields [that] are hingedly attached to the hub of the needle cannula”).
There can be no literal infringement where a claim requires two separate structures and one such structure is missing from an accused device. See Gaus, 363 F.3d at 1288-90 (concluding that where a claim called for “an electrical operating unit and a pair of spaced-apart electrically exposed conductive probe networks,” it required that the two elements be “separate” structures in the accused device). Because the unequivocal language of the asserted claims of the '544 patent requires both a [1256]*1256hinged arm and a spring means, there can be no literal infringement by Tyco’s accused products which, as the district court correctly concluded, do not contain a spring means that is a separate structural element from the hinged arm and its hinges. See Summary Judgment Decision, 2004 WL 2075413 at *2-3, 2004 U.S. Dist. LEXIS 18637 at *9.5
In rejecting Tyco’s argument that the asserted claims require an added spring member, the district court noted that “the abstract of the '544 patent states that a spring may be provided to assist movement of the guard toward the distal shielded position. It does not state that a spring must be provided.” Summary Judgment Decision, 2004 WL 2075413 at *3-4, 2004 U.S. Dist. LEXIS 18637 at *12 (emphases added). It is true that the '544 patent states that “a spring may be provided to assist movement of the guard.” This language, however, refers to the fact that the patent has three independent claims and only two of them include a spring means limitation. Independent claim 17, which is not now asserted against Tyco, contains the identical hinged arm limitation found in independent claims 1 and 24 but, unlike the asserted claims, does not contain an added spring means limitation.6 Thus, while all three independent claims require a hinged arm comprised of two plastic segments which are “articulated to” each other, “articulated to” the guard, and “articulated to” the needle assembly, only the asserted claims call for an added spring member.
[1257]*1257Claims must be “interpreted with an eye toward giving effect to all terms in the claim.” Bicon, Inc. v. Straumann Co., 441 F.3d 945, 950 (Fed.Cir.2006). If the spring means limitation contained in claims 1 and 24 — but not in claim 17 — is not to be read out of the asserted claims, it must require an additional element beyond that which is already called for by the hinged arm limitation. See Cat Tech LLC v. Tube-Master, Inc., 528 F.3d 871, 885 (Fed.Cir.2008) (refusing to adopt a claim construction which would render a claim limitation meaningless); Elekta Instrument S.A. v. O.U.R. Scientific Int’l, Inc., 214 F.3d 1302, 1305-07 (Fed.Cir.2000) (refusing to adopt a claim construction which would render claim language superfluous). Simply put, a claim construction that does not require a spring member in addition to the hinged arm structure renders the spring means limitation functionally meaningless. See Bicon, 441 F.3d at 950 (“Allowing a patentee to argue that physical structures and characteristics specifically described in a claim are merely superfluous would render the scope of the patent ambiguous, leaving examiners and the public to guess about which claim language the drafter deems necessary to his claimed invention....”).
II.
Furthermore, even under the trial court’s erroneous claim construction, Becton adduced no credible evidence establishing literal infringement by Tyco’s accused products. The thrust of Becton’s infringement argument was that the hinges in Tyco’s needles contain stored energy and that when the hinged arm is unlatched, the hinges act as “springs” that cause the guard to move down the needle cannula. The fatal defect in this theory is that Becton failed to produce any evidence that this posited movement ever occurred. Becton did not provide any test data or even a single live demonstration showing that: 1) the hinges in the accused devices contained stored energy, or 2) they moved the guard even one millimeter down the needle cannula.
Living hinges are thinned pieces of plastic that have a long “flex-life,” meaning that they can bend or flex repeatedly without breaking. Depending on how they are manufactured, such hinges can contain differing amounts of stored energy. The hinges in certain prior art safety needles contained stored energy. Becton, however, failed to produce evidence demonstrating that the hinges in Tyco’s accused devices contained any such stored energy. Tyco’s expert, Mary Boyce, testified without contradiction that any stored energy imparted to the hinges during the manufacturing process quickly dissipates.
An important feature of living hinges is that they have “memory,” i.e., they “remember” past positions and seek to return to them after being bent. Although the hinged arm in Tyco’s safety needle is initially molded in a flat configuration, it is bent into a folded position during the manufacturing process. During the final step of the manufacturing process, the fully-assembled needle, with the hinged arm folded and latched, is placed in a sealed package and sterilized with gamma radiation. This irradiation changes the molecular structure of the hinges so that the folded position of the hinged arm has become the neutral or “relaxed” position to which the hinged arm, if moved, will tend to return.
At trial, Tyco demonstrated repeatedly that once the hinged arms in the accused devices were unlatched,7 the hinges never pushed the guard down the needle cannu[1258]*1258la. No “spring” from the living hinges was ever demonstrated. To the contrary, if at any time during the period when the guard was being manually pushed down the needle cannula the user removed his finger from the hinged arm, the hinged arm moved backwards toward its original folded position. Instead of pushing the guard toward the tip of the needle, as required by the asserted claims, the living hinges in the accused devices tended to move the hinged arm backwards toward the needle hub.
Thus, as the district court correctly acknowledged, Beeton’s “direct evidence regarding the movement of the guard [was] insufficient to support the jury’s finding of infringement.” JMOL Decision, 2008 WL 4610220 at *4 n. 2, 2008 U.S. Dist. LEXIS 82915 at *11 n. 2. The court, however, refused to set aside the jury’s verdict. It reasoned that because the accused devices have a latch that holds the hinged arm in a folded position, the hinges might contain some stored energy that might be capable of moving the guard some distance down the needle cannula. Id. at *3-5, 2008 U.S. Dist. LEXIS 82915 at *10-15.
It is undisputed that the accused devices contain a latch. It is also beyond cavil that a living hinge can contain stored energy and that if that hinge is held back by a latch and then released, it could act as a spring. Not every hinge contains stored energy, however, and not every device with a latch acts as a spring. A door, for example, can have both hinges and a latch, but does not necessarily spring open when unlatched. Although Becton had ample opportunity to do so, it failed to demonstrate either that the hinges in Tyco’s safety needles contained any stored energy or that they pushed the guard forward after the latch was released. Instead, as Tyco explained at trial, the latches on the accused safety needles were designed not to restrain stored energy, but to prevent the shield from being accidently activated or dislodged prior to use.
The Magellan products were initially developed by Specialized Health Products, Inc. (“SHPI”), a small Utah company that designs safety needles for several larger medical companies, including both Tyco and Becton. Mark Ferguson, an SHPI mechanical engineer, testified that the Magellan safety needles and blood collection devices were specifically designed not to include a “spring assist” feature. Instead, they were intended to allow for “full manual control of the activation of the [safety] guard.” The reason for this was that many “clinicians ... didn’t care for the abrupt activation of spring-assisted devices.” Furthermore, a spring-assisted blood collection device can activate so rapidly that blood remaining on a needle after use can splatter, increasing the risk of disease transmission. Ferguson stated unequivocally that “[t]he living hinges in the [1259]*1259Magellan [products] are not springs,” and that “[a]n operator, the nurse or [the] doctor, is the only thing ... that moves the guard toward the needle tip.”
Contrary to Becton’s assertions, the testimony of Garris, Becton’s expert, is insufficient to support the jury’s verdict. See id. at *4 n. 2, 2008 U.S. Dist. LEXIS 82915 at *11 n. 2 (emphasizing that “Garris’ testimony regarding the spring assist of Tyco’s Monoject Magellan devices is entitled to little, if any, weight, because it is directed to a combination of forces that cause movement of the guard, not the spring by itself’). Garris, in preparing his expert report, artificially created a “spring” movement in the hinges. At his deposition, Garris admitted that he had repeatedly extended and refolded the hinged arms of the accused devices. Garris was never able to demonstrate that the hinges in the accused products, as manufactured and sold, contained stored energy which moved the guard toward the needle tip. To the contrary, Garris produced no test evidence and no measurements showing that the hinges contained stored energy or that they moved the guard even the smallest distance after unlatching.
Becton claims that video clips of Tyco’s expert, Boyce, removing the latch from an accused needle demonstrates that a spring moves the needle guard down the needle cannula. As the district court correctly concluded, however, “Dr. Boyce’s videos ... are not sufficient to support the jury’s verdict.” Id. Boyce did a series of tests in which she attempted to cut the latch off of an accused needle while the hinged arm was still latched. In these tests, however, the guard never moves to the position it would be in after an actual device is unlatched. Nothing in the Boyce videos, therefore, demonstrates that the hinges in the accused devices, as manufactured and sold, move the guard toward the tip of the needle after the hinged arm is unlatched.
Becton also asserts that a force-displacement test conducted by Boyce “shows that the living hinges exert a force immediately after unlatching that helped the artificial finger move the guard forward.” As a preliminary matter, it should be noted that even if it had been established that the hinges “helped” the artificial finger move the .guard, this would not be sufficient to meet the trial court’s claim construction, which required that the hinged arm move the guard “by itself’ at least some distance toward the tip of the needle.8 Even more fundamentally, Bee[1260]*1260ton never argued at trial that Boyce’s force displacement test showed that the hinges contributed in any way to the movement of the guard. No witness, either on direct or cross-examination, testified that Boyce’s tests reflected any such movement. Unsupported attorney argument, presented for the first time on appeal, is an inadequate substitute for record evidence. See Gemtron Corp. v. Saint-Gobain Corp., 572 F.3d 1371, 1380 (Fed.Cir.2009) (emphasizing that “unsworn attorney argument ... is not evidence”).
Becton makes much of the fact that “the accused devices themselves were in evidence, and the jury was able to examine them.” The jury, however, was not free to disregard the overwhelming record evidence showing that no movement of the guard occurred after the hinged arm was unlatched and instead to “infer” that the hinges might contain some stored energy that might be capable of moving the guard down the needle cannula. It is inconceivable that the jury, by examining the accused devices, could see the hinges move the guard when Becton, despite repeated opportunities to do so, was unable to demonstrate that such movement ever occurred. A jury verdict based on inferences wholly unsupported by the record cannot stand. See Lightning Lube, 4 F.3d at 1166 (JMOL is appropriate “if, upon review of the record, it is apparent that the verdict is not supported by legally sufficient evidence.”).
III.
In its quixotic quest to establish infringement of the '544 patent, Becton argues that Tyco’s accused needles do, in fact, have springs that are separate structures from the hinged arm. In support, it contends that the hinges in the hinged arm are separate structures from the hinged arm itself. This argument is unavailing. A “hinged arm,” by definition, must include at least one hinge. Becton, in fact, concedes in its brief on appeal that the middle hinge, which connects the proximal and distal segments of the hinged arm “is part of the hinged arm.” It argues, however, that the two other hinges of the hinged arm — one which connects the arm to the needle hub and one which connects the arm to the guard — are separate structures from the hinged arm and can therefore satisfy the spring means limitation of the asserted claims.9 An insurmountable problem with this theory is that the spring means limitation requires not only a spring, but a spring that moves the guard down the needle cannula. See '544 patent col.7 11.33-35 (requiring that the spring means “urge” the guard down the needle cannula). Thus, even if the hinges other than the middle hinge were separate structures from the hinged arm (which they are [1261]*1261not) and Becton had produced evidence that the hinges moved the guard down the needle cannula (which it did riot), Becton never established that any hinge other than the middle hinge connecting the two segments of the hinged arm caused such movement. In other words, even if the hinges other than the middle hinge could be considered separate structures from the hinged arm, there is no evidence that they function as springs that move the guard down the needle cannula.
We likewise reject Becton’s argument that the district court erred in granting Tyco’s motion for an order in limine precluding Becton from presenting evidence that Tyco’s accused products infringed the '544 patent during the manufacturing process. After Boyce, Tyco’s expert, submitted her expert report concluding that any energy imparted to the hinges in Tyco’s accused products quickly dissipates, Becton attempted to rely on the fact that the hinges might contain some stored energy during the manufacturing process. Because Becton’s argument — that a version of Tyco’s products that existed temporarily during the manufacturing process might infringe the '544 patent — -was not properly raised during discovery, the district court did not abuse its discretion in precluding Becton from presenting evidence regarding this theory at trial.10 See Acumed LLC v. Advanced Surgical Servs., Inc., 561 F.3d 199, 211 (3d Cir.2009) (In order to show that a trial court abused its discretion in issuing an evidentiary ruling, “an appellant must show that the court’s decision was arbitrary, fanciful or clearly unreasonable.” (citations and internal quotation marks omitted)).
Conclusion
Accordingly, the judgment of the United States District Court for the District of Delaware is reversed.
REVERSED.